ResearcherBen-Gurion University of the NegevActive in the last 2 years
Lior Rokach
Matched on ORCID iD 0000-0002-6956-3341; OpenAlex author ID A5012622155, A5135243142.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Collaborators
- 2
2024: 1 paper · 2025: none · 2026: 1 paper
Papers 2
- Investigating the anticancer activity of eravacycline in pancreatic cancer via target-based deep learning and experimental validation. Co-author DOI 10.1093/bib/bbag353↗
- Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model. Last author DOI 10.1093/bib/bbae108↗
Closest collaborators
The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Shimon Ben-Shabat · 2 shared papers, 2024–2026
- Paper Investigating the anticancer activity of eravacycline in pancreatic cancer via target-based deep learning and experimen… DOI 10.1093/bib/bbag353↗
- Paper Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep lea… DOI 10.1093/bib/bbae108↗
- Adi Jabarin · 2 shared papers, 2024–2026
- Paper Investigating the anticancer activity of eravacycline in pancreatic cancer via target-based deep learning and experimen… DOI 10.1093/bib/bbag353↗
- Paper Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep lea… DOI 10.1093/bib/bbae108↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.